Quantitative Metabolomics and Lipoprotein Analysis of PDAC Patients Suggests Serum Marker Categories for Pancreatic Function, Pancreatectomy, Cancer Metabolism, and Systemic Disturbances

Author:

Bae Gyuntae12,Berezhnoy Georgy1,Flores Alejandra1,Cannet Claire3,Schäfer Hartmut3,Dahlke Marc H.4,Michl Patrick5,Löffler Markus W.67289,Königsrainer Alfred672,Trautwein Christoph1210ORCID

Affiliation:

1. Werner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, University Hospital Tübingen, Tübingen 72076, Germany

2. Cluster of Excellence iFIT (EXC2180) ‘Image-Guided and Functionally Instructed Tumor Therapies’, University of Tübingen, Tübingen 72076, Germany

3. Bruker BioSpin GmbH & Co. KG, BioPharma and Applied Division, Ettlingen 76275, Germany

4. Department of General and Visceral Surgery, Robert-Bosch-Krankenhaus, Stuttgart 70376, Germany

5. Dept of Internal Medicine IV, University Hospital Heidelberg, Heidelberg 69120, Germany

6. Department of General, Visceral and Transplant Surgery, University Hospital Tübingen, Tübingen 72076, Germany

7. German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ) Partner Site Tübingen, University of Tübingen, Tübingen 72076, Germany

8. Department of Immunology, University of Tübingen, Tübingen 72076, Germany

9. Department of Clinical Pharmacology, University Hospital Tübingen, Tübingen 72076, Germany

10. M3 Research Center for Malignome, Metabolome and Microbiome, Faculty of Medicine University Tübingen, Tübingen 72076, Germany

Funder

German Federal Ministry of Science and Education (BMBF)

Publisher

American Chemical Society (ACS)

Reference76 articles.

1. Pancreatic ductal adenocarcinoma: Treatment hurdles, tumor microenvironment and immunotherapy

2. U. S. National Institutes of Health, National Cancer Institute. SEER Training Modules, Cancer Stat Facts: Pancreatic Cancer. 2023. https://seer.cancer.gov/statfacts/html/pancreas.html (accessed 11 July 2023).

3. Advances in biomarkers and techniques for pancreatic cancer diagnosis

4. Long-Term Survivors of Pancreatic Cancer

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3